Day: December 5, 2022

Two Young Entrepreneurs Bet on NFTs and Select WISe.Art Marketplace to Sale Their New Series of NFT Watches Geneva, Madrid – December 5, 2022 – WISeKey International Holding Ltd. (“WISeKey”) (SIX: WIHN, NASDAQ: WKEY), a leading global cybersecurity, AI, Blockchain and IoT company, today announced that its 3.0 NFT Marketplace WISe.ART will create a series of NFTs for watches connecting owners with their WISeID. WISeID is a trusted identity service provided by WISeKey that enables access to the web and mobile applications with strong authentication techniques. Eduardo Beltrà Ferre and José Gutierrez Blanco will soon release the brand-new series of NFT watches designed by renowned artist Pedro Sandoval, master of the art of animated video making who is one of the WISe.ART NFT platform’s early adopters. They chose to elect WISe.ART...

Today Kvika banki hf. sold nominal ISK 560 million in the bond series KVIKA 25 1201 GB at the price of 100.00, a 1.25% spread over the 3M REIBOR interest rate. The bonds have a maturity of 3 years and pay interest quarterly. Following the tap issuance, the total amount issued in the series will be ISK 1,660 million. The bonds are expected to be issued and admitted to trading on Nasdaq Iceland’s sustainable debt market on 8 December 2022. The bonds will be issued under the bank’s domestic debt programme with reference to its green financing framework. For further information please contact Kvika‘s investor relations at ir@kvika.is or via tel. (+354) 540 3200.

Monies RAISED in the Community STAY in the Community LAS VEGAS, Dec. 05, 2022 (GLOBE NEWSWIRE) — Tough Enough to Wear Pink™ (TETWP), the Western Community’s grassroots campaign to raise awareness and funds for breast cancer returns to Las Vegas’s Thomas & Mack Center to celebrate the 18th annual Tough Enough to Wear Pink Night. Since its inception, the ten-day rodeo championship has raised life-altering funds for the cause. “This year, we have fundraised $39 million to date,” shares Lacey Wheatley, Executive Director of Tough Enough to Wear Pink. “We are excited to have the honor of announcing our top fundraising rodeos of the year and recognizing sponsors, volunteers and fans for their support.” The arena promises to be a sea of pink, with rodeo athletes and fans sporting the color in honor of breast cancer awareness....

Point d’avancement au titre du contrat de financement avec European High Growth Opportunities Securitization Fund Rappel du contexte NEOLIFE (Euronext Growth Paris – Code ISIN FR0011636083 – Mnémonique ALNLF) (la « Société ») a signé début juillet 2022 un contrat de financement avec le fonds d’investissement luxembourgeois European High Growth Opportunities Securitization Fund (l’« Investisseur »). Cette ligne de financement flexible sur 18 mois, par émission de 400 bons d’émission d’obligations convertibles ou échangeables en actions nouvelles et/ou existantes d’une valeur nominale de 5.000 euros chacune (les « OCEANE »), se décompose en 8 tranches d’un montant nominal maximum de 250.000 euros, correspondant à l’émission d’un nombre maximum de 50 OCEANE chacune. Le montant nominal maximum total des OCEANE ainsi émises sera égal à 2...

COPENHAGEN, Denmark and BOSTON, Dec. 05, 2022 (GLOBE NEWSWIRE) — BioPorto A/S (BioPorto or Company) (CPH:BIOPOR) today announced that Mr. Nis Kruse joined the Company as EVP of Strategic Partnerships and General Manager of EMEA & APAC. He will also serve as site leader for the Hellerup, Denmark office. “We are preparing for the prospective global launch of NGAL tests, having submitted our De Novo application to the US Food and Drug Administration to aid in identifying pediatric patients at risk of moderate to severe Acute Kidney Injury (AKI),” said Tony Pare, BioPorto’s CEO. “Nis’ experience in strategic partnership development, distributor management, and building commercial teams will be a welcome addition to the BioPorto executive team.” Mr. Kruse most recently served as SVP & Chief Commercial Officer at SSI Diagnostica...

December 5, 2022News Release BioPorto adds Mr. Nis Kruse as EVP of Strategic Partnerships and GM of EMEA & APAC COPENHAGEN, DENMARK and BOSTON, MA, December 5, 2022, (GLOBE NEWSWIRE) — BioPorto A/S (BioPorto or Company) (CPH:BIOPOR) today announced that Mr. Nis Kruse joined the Company as EVP of Strategic Partnerships and General Manager of EMEA & APAC. He will also serve as site leader for the Hellerup, Denmark office. “We are preparing for the prospective global launch of NGAL tests, having submitted our De Novo application to the US Food and Drug Administration to aid in identifying pediatric patients at risk of moderate to severe Acute Kidney Injury (AKI),” said Tony Pare, BioPorto’s CEO. “Nis’ experience in strategic partnership development, distributor management, and building commercial teams will be a welcome addition...

              DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS       Information on the total number of voting rights and of shares representing the share capital (Article 223-16 of the General regulations of the French Financial Market Authority – Autorité des Marchés Financiers)         Quotation place: Euronext Paris Compartiment A ISIN code: FR0000031577  Date Total number of shares representing the share capital Total number of voting rightsNovember, 30 2022 8 458 000 Gross total of voting rights : 12 765 861Net total* of voting rights : 12 751 087  Net total* = total number of voting rights attached to the total number of shares net of shares with no voting rights.               VIRBAC: Shaping the future of animal health NYSE Euronext – Compartiment A / Code ISIN: FR0000031577 / MNEMO: VIRP Corporate Finance:...

BURBANK, CA, Dec. 05, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Quanta, Inc. (the “Company”) (OTC PINK: QNTA), an applied sciences company based on a patented quantum biology platform that significantly boosts the potency and efficiency of any plant-based matter, provided today an update for its shareholders on the recent activities and plans for the future of the Company and its majority owned subsidiary, Medolife Rx, Inc. In the recent months, the Company has been focused on navigating through serious challenges. The Company acknowledges the drop in the price of its common stock and the delinquent status with the SEC reporting requirements. The Company provides this update on both its corporate and operational status and its plans to address these matters.Due to operating losses and lack of capital investment, the Company...

  DASSAULT AVIATION   French corporation (société anonyme) with a share capital of 66,789,624 euros Headquarters: 9, Rond-Point des Champs-Elysées Marcel Dassault – 75008 PARIS RCS PARIS 712 042 456     Information concerning the total number of voting rights and shares as per article L. 233-8 II of the French Commercial Code (Code de commerce) and article 223-16 of the General Regulations (Règlement Général) of the French Market Authority (Autorité des Marchés Financiers)        DateTotal number of sharesTotal number of voting rights11/30/2022 83,487,030Theoretical voting rights: 135,558,208 Exercisable voting rights: 134,868,706   AttachmentTotal number of shares and voting rights – 30 11 22